
Carolene Therapeutics Private Limited
This company imports, exports, and sells pharmaceuticals, healthcare products, and medicinal goods.
This company imports, exports, and sells pharmaceuticals, healthcare products, and medicinal goods.
Carolene Therapeutics Private Limited (CTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 July 2020 (Four years and nine months 30 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Nerkar and Shivanand Mante serve as directors at the Company.
Aurangabad, Maharashtra, India
+91-XXXXXXXXXX
U24100PN2020PTC191871
191871
Private Limited Indian Non-Government Company
11 Jul 2020
30 Sep 2023
31 Mar 2023
Unlisted
Roc Pune
Carolene Therapeutics Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Sexual Wellness Products, Fertility Enhancer, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Vitamin Tablets & Capsules, Antibiotic Injection, Vitamin & Multivitamin Injections.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shivanand Mante ![]() | Director | 11-Jul-2020 | Current |
Amit Nerkar ![]() | Director | 11-Jul-2020 | Current |
Carolene Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 807.75% increase. The company also saw a substantial improvement in profitability, with a 28.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 98.77%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Carolene Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Amit Nerkar is a mutual person
There are no open charges registered against the company as per our records.
Carolene Therapeutics has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Carolene Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Carolene Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Carolene Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Carolene Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune.
Amit Gajanan Nerkar was appointed as a Director was appointed as a Director on 11 Jul 2020 & has been associated with this company since 4 years 9 months .
Shivanand Arjun Mante was appointed as a Director was appointed as a Director on 11 Jul 2020 & has been associated with this company since 4 years 9 months .
Carolene Therapeutics Private Limited was registered on 11 Jul 2020 with Roc Pune & aged 4 years 9 months as per MCA records.
Carolene Therapeutics Private Limited was incorporated on 11 Jul 2020.
The authorized share capital of Carolene Therapeutics Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Carolene Therapeutics Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Carolene Therapeutics Private Limited is Shop No. 25 S. A1 1St Floor, Chinar Arcade Padegaon India, Aurangabad, Maharashtra, 431001.
The corporate identification number (CIN) of Carolene Therapeutics Private Limited is U24100PN2020PTC191871 and the company number is 191871 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Carolene Therapeutics Private Limited has risen by 807.75%.
The financial reports for the fiscal year 2022 indicates that The net worth of Carolene Therapeutics Private Limited has experienced an downturn of -98.77%.
The most recent Balance Sheet for Carolene Therapeutics Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.